Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Prescriber Patterns of SGLT2i After Expansions of U.S. Food and Drug Administration Labeling.

× No keyword cloud information.

32 in total

Review 1. Sodium-glucose cotransporter inhibitors in type 2 diabetes: thinking beyond glucose lowering.

Authors: Brendon L Neuen; David Z Cherney; Meg J Jardine; Vlado Perkovic
Journal: CMAJ Date: 2019-10-15 Impact factor: 8.262

Review 2. Addressing Comorbidities in Heart Failure: Hypertension, Atrial Fibrillation, and Diabetes.

Authors: Aakash Bavishi; Ravi B Patel
Journal: Heart Fail Clin Date: 2020-07-21 Impact factor: 3.179

3. Implications of Specialist Density for Diabetes Care in the United States.

Authors: Ravi B Patel; Mahmoud Al Rifai; John W McEvoy; Muthiah Vaduganathan
Journal: JAMA Cardiol Date: 2019-11-01 Impact factor: 14.676

Review 4. Bridging the Gap for Patients with Diabetes and Cardiovascular Disease Through Cardiometabolic Collaboration.

Authors: Lee-Shing Chang; Muthiah Vaduganathan; Jorge Plutzky; Vanita R Aroda
Journal: Curr Diab Rep Date: 2019-12-04 Impact factor: 4.810

5. Patient and Provider Characteristics Associated With Sodium-Glucose Cotransporter 2 Inhibitor Prescription in Patients With Diabetes and Proteinuric Chronic Kidney Disease.

Authors: Ian E McCoy; Jialin Han; Maria E Montez-Rath; Glenn M Chertow; Jinnie J Rhee
Journal: Clin Diabetes Date: 2020-07

Review 6. Dedicated kidney disease-focused outcome trials with sodium-glucose cotransporter-2 inhibitors: Lessons from CREDENCE and expectations from DAPA-HF, DAPA-CKD, and EMPA-KIDNEY.

Authors: Jinnie J Rhee; Meg J Jardine; Glenn M Chertow; Kenneth W Mahaffey
Journal: Diabetes Obes Metab Date: 2020-04 Impact factor: 6.577

7. Trends in Clinical Characteristics and Prescribing Preferences for SGLT2 Inhibitors and GLP-1 Receptor Agonists, 2013-2018.

Authors: Chintan V Dave; Sebastian Schneeweiss; Deborah J Wexler; Gregory Brill; Elisabetta Patorno
Journal: Diabetes Care Date: 2020-02-10 Impact factor: 19.112

8. Relative frequency of cardiology vs. endocrinology visits by type 2 diabetes patients with cardiovascular disease in the USA: implications for implementing evidence-based use of glucose-lowering medications.

Authors: Felona Gunawan; Michael E Nassif; Caitlin Partridge; Tariq Ahmad; Mikhail Kosiborod; Silvio E Inzucchi
Journal: Cardiovasc Endocrinol Metab Date: 2020-05-15

Review 9. Cardioprotective diabetes drugs: what cardiologists need to know.

Authors: Jenifer M Brown; Brendan M Everett
Journal: Cardiovasc Endocrinol Metab Date: 2019-11-13

10. Prescription of Glucagon-Like Peptide-1 Receptor Agonists by Cardiologists.

Authors: Muthiah Vaduganathan; Ravi B Patel; Avinainder Singh; Cian P McCarthy; Arman Qamar; James L Januzzi; Benjamin M Scirica; Javed Butler; Christopher P Cannon; Deepak L Bhatt
Journal: J Am Coll Cardiol Date: 2019-04-02 Impact factor: 24.094